Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Abroad (travel likely)RecruitingPHASE1

Conditions

Relapsed/Refractory Systemic Lupus Erythematosus · Relapsed/Refractory Systemic Sclerosis · Relapsed/Refractory Idiopathic Inflammatory Myopathies · Relapsed/Refractory sjögren's Syndrome · Relapsed/Refractory Autoimmune Hemolytic Anemia · Relapsed/Refractory Multiple Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing GoBroad Boren Hospital, Beijing, China
Contact: Study coordinator (Yajing Zhang) · yajing_cart66@126.com · +86 18501333856

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus · Lupus Nephritis · Autoimmune Diseases

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Autoimmune Diseases · Systemic Lupus Erythematosus · Systemic Sclerosis

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Systemic Lupus Erythematosus · Lupus Nephritis (LN) · Sjogren's Syndrome

Abroad (travel likely)RecruitingPHASE1

Bengbu, China

Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

Systemic Lupus Erythematosus (SLE) · Systemic Sclerosis · Sjogren's Syndrome (SS)

Abroad (travel likely)RecruitingPHASE1

Xuzhou, China · Xuzhou, China